Directors dealings: Hikma chief dips back in after gout victory

By

Sharecast News | 27 Jun, 2016

Updated : 15:19

Hikma Pharmaceuticals chief executive Said Darwazah has further boosted his stake in the company with a huge £3.3m purchase of shares.

Darwazah, whose father set up Hikma in 1978, showed his confidence in the company with a purchase of 150,000 shares at a price of 2,200p, almost a fortnight after he spent £1.52m on 70,000 shares.

He now owns 13.3m shares, of 5.56% of the total.

Drwazah's deals come a few weeks after a US court ruled in favour of Hikma and its wholly-owned US subsidiary West-Ward Pharmaceutical by dismissing claims made by Takeda Pharmaceuticals for alleged infringement of patents covering methods of use of Takeda's colchicine product, Colcrys, to treat gout.

Hikma has been marketing its own colchicine product under the brand name Mitigare since January 2015 and selling an authorised generic.

Gout, known as the 'disease of kings' as it afflicted many monarchs, including Henry VIII, is making a painful resurgence in the UK due to growing levels obesity and heavy drinking.

Top Director Buys

Hikma Pharmaceuticals (HIK)
Director name: Al-Husry,Ali
Amount purchased: 150,000 @ 2,200.00p
Value: £3,300,000.00

Hikma Pharmaceuticals (HIK)
Director name: Darwazah,Mazen
Amount purchased: 150,000 @ 2,200.00p
Value: £3,300,000.00

Hikma Pharmaceuticals (HIK)
Director name: Darwazah,Said
Amount purchased: 150,000 @ 2,200.00p
Value: £3,300,000.00

Royal Mail (RMG)
Director name: Long,Peter James
Amount purchased: 50,000 @ 471.40p
Value: £235,700.01

Watkin Jones (WJG)
Director name: Turner,Grenville
Amount purchased: 90,900 @ 106.40p
Value: £96,717.60

Auto Trader Group (AUTO)
Director name: Keens,David W
Amount purchased: 25,000 @ 358.49p
Value: £89,622.50

Savills (SVS)
Director name: Ferguson,Nicholas
Amount purchased: 15,000 @ 587.39p
Value: £88,108.80

Electrocomponents (ECM)
Director name: Ruth,Lindsley
Amount purchased: 20,000 @ 266.00p
Value: £53,200.00

Is Solutions (ISL)
Director name: Simmonds ,Peter
Amount purchased: 40,000 @ 118.60p
Value: £47,440.00

Wpp (WPP)
Director name: Susman,Simon Sally
Amount purchased: 2,500 @ $21.29
Value: $42,055.62

Wpp (WPP)
Director name: Seligman,Nicole
Amount purchased: 2,500 @ $20.80
Value: $41,083.23

Taylor Wimpey (TW.)
Director name: Barker ,Kate
Amount purchased: 20,000 @ 134.77p
Value: £26,953.44

Informa (INF)
Director name: Flaschen,David
Amount purchased: 3,000 @ $9.05
Value: $21,450.60

Prudential (PRU)
Director name: Turner,Lord J Adair
Amount purchased: 1,500 @ 1,178.00p
Value: £17,670.00

Hogg Robinson Group (HRG)
Director name: Krumins,John
Amount purchased: 20,000 @ 64.81p
Value: £12,962.00

Primary Health Properties (PHP)
Director name: Holland ,Phil
Amount purchased: 10,000 @ 104.12p
Value: £10,412.50

Marshalls (MSLH)
Director name: Allner,Andrew
Amount purchased: 3,943 @ 253.58p
Value: £9,998.66

Marshalls (MSLH)
Director name: Allner,Andrew
Amount purchased: 3,927 @ 254.45p
Value: £9,992.25

Challenger Acquisitions Limited (CHAL)
Director name: Gustafson,Mark
Amount purchased: 30,000 @ 22.90p
Value: £6,870.00

Vertu Motors (VTU)
Director name: Forrester,Robert
Amount purchased: 11,215 @ 44.55p
Value: £4,996.28

Challenger Acquisitions Limited (CHAL)
Director name: Gustafson,Mark
Amount purchased: 20,000 @ 24.85p
Value: £4,970.00

Challenger Acquisitions Limited (CHAL)
Director name: Gustafson,Mark
Amount purchased: 20,000 @ 24.70p
Value: £4,940.00

Challenger Acquisitions Limited (CHAL)
Director name: Gustafson,Mark
Amount purchased: 20,000 @ 24.45p
Value: £4,890.00

Challenger Acquisitions Limited (CHAL)
Director name: Gustafson,Mark
Amount purchased: 20,000 @ 23.95p
Value: £4,790.00

Oxford Biomedica (OXB)
Director name: Tallarigo ,Lorenzo
Amount purchased: 62,847 @ 4.20p
Value: £2,639.57

Last news